Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | Director · President & CEO | October 12, 2026 | October 13, 2026 |
| Gamida Cell Ltd.GMDA · Entity 94655 | Director | February 08, 2023 | February 11, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 278,544 |
Ending reported balance
After 2026-10-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-12 · Exercise / conversion · Acquired 7,500 · Balance 286,044 Row 2 · 2026-10-12 · Sale · Disposed 7,500 · Balance 278,544 |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.60 · Expires 2027-02-28 | Direct | 141,745 |
Reported balance
After 2026-10-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-12 · Exercise / conversion · Disposed 7,500 · Balance 141,745 |
| Common StockSEC Table I · non-derivative | Indirectby Trust 1. Beneficial Ownership disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,083 F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
| Common StockSEC Table I · non-derivative | Indirectby Trust 2. Beneficial Ownership Disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,083 F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Gamida Cell Ltd.
Report date February 08, 2023 · Filed February 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 96,500 |
Ending reported balance
After 2023-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-08 · Grant · Acquired 28,300 · Balance 82,300 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. Row 2 · 2023-02-08 · Grant · Acquired 14,200 · Balance 96,500 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 56,600 |
Reported balance
After 2023-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-08 · Grant · Acquired 56,600 · Balance 56,600 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 28,300 |
Reported balance
After 2023-02-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-08 · Grant · Acquired 28,300 · Balance 28,300 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.
F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2019 Filed Dec 17, 2019 21:24 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $10.22 | $61,326.00 |
DisclosureSEC source: 0001061983-19-000073 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,057 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $8.08 | $48,508.20 |
DisclosureSEC source: 0001061983-19-000067 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,057 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $11.16 | $66,975.00 |
DisclosureSEC source: 0001061983-19-000063 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $12.74 | $76,469.40 |
DisclosureSEC source: 0001061983-19-000059 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 21:45 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $12.64 | $75,814.80 |
DisclosureSEC source: 0001061983-19-000055 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 21:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $10.94 | $65,632.20 |
DisclosureSEC source: 0001061983-19-000050 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:52 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 6,000 | $9.71 | $58,238.40 |
DisclosureSEC source: 0001061983-19-000046 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 225,099 | $7.14 Strike: $7.14 | $1,607,206.86 |
DisclosureSEC source: 0001061983-19-000021 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,099 Underlying: Common Stock · 225,099 shares Expires 2029-02-26 F4 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 14,901 | $7.14 Strike: $7.14 | $106,393.14 |
DisclosureSEC source: 0001061983-19-000021 · edgardoc.xml · derivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,901 Underlying: Common Stock · 14,901 shares Expires 2029-02-26 F4 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-19-000021 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,022 F1 · deemedExecutionDate: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 22:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $7.11 | $28,432.00 |
DisclosureSEC source: 0001061983-19-000002 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 21:57 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $7.50 | $29,988.40 |
DisclosureSEC source: 0001061983-18-000056 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 16:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $7.11 | $28,446.00 |
DisclosureSEC source: 0001061983-18-000053 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| October 05, 2018 Filed Oct 5, 2018 23:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $8.79 | $35,178.00 |
DisclosureSEC source: 0001061983-18-000049 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 20:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $7.94 | $31,768.80 |
DisclosureSEC source: 0001061983-18-000044 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 21:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $6.65 | $26,582.40 |
DisclosureSEC source: 0001061983-18-000042 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:33 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $9.09 | $36,372.40 |
DisclosureSEC source: 0001061983-18-000038 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 22:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $8.28 | $33,116.40 |
DisclosureSEC source: 0001061983-18-000033 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| May 04, 2018 Filed May 4, 2018 22:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,500 | $8.40 | $12,600.00 |
DisclosureSEC source: 0001061983-18-000022 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| May 04, 2018 Filed May 4, 2018 22:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,800 | $8.38 | $15,075.00 |
DisclosureSEC source: 0001061983-18-000022 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,522 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| May 04, 2018 Filed May 4, 2018 22:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 400 | $8.35 | $3,340.00 |
DisclosureSEC source: 0001061983-18-000022 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,322 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| May 04, 2018 Filed May 4, 2018 22:08 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 300 | $8.30 | $2,490.00 |
DisclosureSEC source: 0001061983-18-000022 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,722 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| April 05, 2018 Filed Apr 6, 2018 22:01 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 4,000 | $7.52 | $30,090.40 |
DisclosureSEC source: 0001061983-18-000020 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,701 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 8,298 | $7.75 | $64,309.50 |
DisclosureSEC source: 0001061983-18-000013 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,701 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 15,681 | $7.75 | $121,527.75 |
DisclosureSEC source: 0001061983-18-000013 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,999 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 45,000 | $0.00 | $45.00 |
DisclosureSEC source: 0001061983-18-000013 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,680 Read SEC document |
| February 27, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 190,454 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-18-000013 · edgardoc.xml · derivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,454 Underlying: Common Stock · 190,454 shares Expires 2028-02-27 F4 · derivative.exercise_date: When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022. Read SEC document |
| February 27, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 9,546 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-18-000013 · edgardoc.xml · derivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,546 Underlying: Common Stock · 9,546 shares Expires 2028-02-27 F4 · derivative.exercise_date: When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022. Read SEC document |
| February 27, 2018 Filed Mar 2, 2018 00:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 100,000 | $0.00 | $100.00 |
DisclosureSEC source: 0001061983-18-000013 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,680 F1 · balance_after: The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/27/2019, 40% on 02/27/2020 and 20% on 03/01/2021. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 252 | $13.80 | $3,477.60 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 13 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,680 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 347 | $13.70 | $4,753.90 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 12 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,932 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.68 | $1,367.50 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 11 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,279 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,000 | $13.65 | $13,650.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 10 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,379 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,000 | $13.60 | $13,600.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 9 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,379 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1 | $13.58 | $13.58 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 8 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,379 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.58 | $1,357.50 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,380 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 200 | $13.55 | $2,710.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,480 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.43 | $1,342.50 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,680 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 1,100 | $13.40 | $14,740.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,780 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 200 | $13.38 | $2,675.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,880 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $13.15 | $1,315.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,080 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| November 01, 2017 Filed Nov 4, 2017 00:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 500 | $13.10 | $6,550.00 |
DisclosureSEC source: 0001061983-17-000063 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 22:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 300 | $14.68 | $4,402.50 |
DisclosureSEC source: 0001061983-17-000058 · edgardoc.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 22:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 2,790 | $14.65 | $40,873.50 |
DisclosureSEC source: 0001061983-17-000058 · edgardoc.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,185 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 22:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $14.60 | $1,460.00 |
DisclosureSEC source: 0001061983-17-000058 · edgardoc.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,975 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 22:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 810 | $14.55 | $11,785.50 |
DisclosureSEC source: 0001061983-17-000058 · edgardoc.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,075 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 22:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 700 | $14.45 | $10,115.00 |
DisclosureSEC source: 0001061983-17-000058 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 22:53 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 300 | $14.40 | $4,320.00 |
DisclosureSEC source: 0001061983-17-000058 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,585 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 100 | $15.28 | $1,527.50 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 11 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 23:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 400 | $14.90 | $5,960.00 |
DisclosureSEC source: 0001061983-17-000054 · edgardoc.xml · nonDerivative · entry 10 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.